Simplify Logo

Full-Time

Quality Operations Manager/Sr Manager

Confirmed live in the last 24 hours

Corcept Therapeutics

Corcept Therapeutics

201-500 employees

Develops cortisol modulators for medical conditions

Biotechnology
Healthcare

Compensation Overview

$150.2k - $215.6kAnnually

Senior, Expert

San Carlos, CA, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets
Requirements
  • Strong technical knowledge of analytical chemistry and pharmaceutical manufacturing technologies and processes
  • Strong experience with executed batch record review and in-depth knowledge of quality and regulatory requirements for the release of pharmaceutical products
  • Ability to work independently and communicate effectively with project team members and management groups and suppliers
  • Work well in a project team environment with solid problem analysis and decision-making ability
  • Ability to lead or support internal and external compliance audits of suppliers, CTLs, and CMOs
  • Ability to work independently in addition to clearly and concisely communicate both in writing and verbally
  • Ability to identify compliance risk and recommend mitigations
  • Ability to author, review, and approve SOPs and other controlled documentation for compliance with applicable regulations
  • Strong statistical mindset and metric presentation
  • Proficient computer skills are needed with experience using Microsoft Word, Excel, PowerPoint, and Visio
  • BS or MS degree in science, engineering or related field
  • At least 10 years in the bio/pharmaceutical industry
  • At least 5-10 years in Quality Assurance
  • Knowledge in application of 21CFR211, global cGMP regulations, and ICH guidelines regarding good manufacturing practices in the development, manufacturing, testing, delivery, and control of pharmaceutical products
Responsibilities
  • Act as Quality lead and support in various Chemistry, Manufacturing and Controls (CMC) projects
  • Work cross-functionally with the CMC group to provide oversight and resolve quality investigations of issues that occur at contract manufacturing and testing organizations
  • Perform review of executed batch records and test data, and perform product disposition
  • Review and approval of validation protocols and reports (e.g., process, method, etc.)
  • Lead and support quality audit of suppliers, CTLs, and CMOs
  • Perform quality trends analysis and reports, recommending continual improvements opportunities

Corcept Therapeutics focuses on developing treatments that regulate cortisol levels in the body, which is important for managing various health issues. Their main product, Korlym, is used to treat Cushing's syndrome, a condition caused by too much cortisol. Korlym was approved by the FDA in 2012 and is the first medication specifically for this disorder. Corcept stands out from competitors by having a strong emphasis on research and development, having discovered over 1,000 unique cortisol modulators. The company aims to expand its range of treatments while also providing educational resources to healthcare professionals and patients to improve understanding and care for cortisol-related conditions.

Company Stage

IPO

Total Funding

$119.1M

Headquarters

Menlo Park, California

Founded

1998

Growth & Insights
Headcount

6 month growth

23%

1 year growth

31%

2 year growth

58%
Simplify Jobs

Simplify's Take

What believers are saying

  • Significant investments from firms like Intrinsic Edge Capital and Jackson Creek Investment Advisors indicate strong market confidence in Corcept's growth potential.
  • The appointment of experienced leaders like Roberto Vieira and Monica Tellado suggests a strategic focus on expanding into oncology and emerging markets.
  • Corcept's commitment to patient and medical education enhances its reputation and fosters better patient outcomes.

What critics are saying

  • Ongoing legal disputes, such as the antitrust lawsuit from Teva, could result in financial and operational setbacks.
  • The loss of the Korlym patent lawsuit to Teva poses a significant threat to Corcept's revenue stream from its flagship product.

What makes Corcept Therapeutics unique

  • Corcept Therapeutics specializes exclusively in cortisol modulation, setting it apart from broader-focused biopharmaceutical companies.
  • Their flagship product, Korlym, is the first FDA-approved treatment for hypercortisolism in Cushing's syndrome, giving them a unique market position.
  • Corcept's extensive R&D pipeline with over 1,000 discovered selective cortisol modulators highlights their commitment to innovation in this niche field.

Help us improve and share your feedback! Did you find this helpful?